RIGI and cancer: It has become increasingly clear that ovarian carcinogenesis follows a dualistic model, with Type‐I cancers behaving fundamentally different from Type‐II cancers, both biologically and clinically.6 To account for this, we compared RIG‐I levels in Type‐I vs. Type‐II cancers, discovering a significant higher RIG‐I expression in the more aggressive Type‐II cancers (p = 0.014, Fig. 2a).